Letters & Comments

NHC Comments on Proposed Rule, Short-Term, Limited-Duration Insurance
(Monday, April 23, 2018)
Letter to Congress Expressing Concern with Short-Term Limited Duration Plans
(Wednesday, April 18, 2018)
Governance Structure
(Tuesday, March 6, 2018)
Staff Reporting Structure
(Tuesday, March 6, 2018)
2017 Policy Matrix
(Tuesday, March 6, 2018)
2018 Work Plan
(Tuesday, March 6, 2018)
2018 Budget
(Tuesday, March 6, 2018)
2017 Audited Financial Statements
(Tuesday, March 6, 2018)
NHC Comments on PFDD Guidance 1 – Collecting Comprehensive and Representative Input
(Friday, February 16, 2018)
NHC Letter on Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act)
(Friday, February 2, 2018)
NHC Comments on Centers for Medicare & Medicaid Services: Innovation Center New Direction
(Monday, November 20, 2017)
NHC Comments on Administering the Hatch-Waxman Amendments: Ensuring a Balance between Innovation and Access
(Friday, November 17, 2017)
120+ Patient Advocates Urge Congress to Reauthorize FDA User Fee Agreements
(Friday, May 5, 2017)
NHC Comments on CMS Announcement of Calendar Year (CY) 2018 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter (Final Call Letter) and Request for Information (RFI)
(Tuesday, April 25, 2017)
NHC Comments on ICER Proposed Update and Patient Participation Guide
(Monday, April 3, 2017)
Letter to Leader McConnell, Leader Reid, Speaker Ryan, and Leader Pelosi
(Tuesday, February 7, 2017)
National Health Council ACA Talking Points
(Thursday, January 5, 2017)
NHC Comments on ICER's Improvements to Value Assessment Framework
(Monday, September 12, 2016)
NHC Comments on MACRA MIPS and APM Proposed Rule
(Monday, June 27, 2016)
NHC Comments on NCATS Strategic Plan
(Friday, January 8, 2016)

Pages